Skip to main content

Advertisement

Table 1 Characteristic of the study population

From: Analysis of health related quality of life (HRQoL) of patients with clinically localized prostate cancer, one year after treatment with external beam radiotherapy (EBRT) alone versus EBRT and high dose rate brachytherapy (HDRBT)

  EBRT group RBRT+HDRB group
No of patients 88 23
Median age (Range) 69(46–84) 69(50–78)
Tumor stage   
   T1 20 4
   T2 59 15
   T3 9 4
Gleason score   
   2–6 55 14
   7 21 7
   8–10 12 2
Pretreatment PSA (ng/ml) Mean: 14.1 Mean: 12.3
  Median: 8.7 Median: 8.9
  Range: 1.7 – 161.8 Range: 0.8 – 51.9
   ≤ 10 46 14
   10–20 31 5
   ≥ 20 11 4
Radiotherapy dose 66–70 Gy/33–35 Fr 40 Gy+16.5 Gy Brachy